RECURRENT GASTRIC CANCER IN PATIENTS UNDERGOING ITS RESECTION. DAGNOSIS OF RECURRENCES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

A set of molecular genetic, immunohistochemical, and biochemical markers is used to diagnose recurrent gastric cancer. To identify the set of additional molecular genetic markers in the postoperative gastric stump mucosal biopsy specimens obtained during endoscopic examination expands information on the risk of a recurrence and process generalization. The paper describes molecular genetic markers that may be used in addition to morphological and biochemical studies for monitoring patients after surgical treatment.

Full Text

Restricted Access

About the authors

A. Chernousov

I.M. Sechenov First Moscow State Medical University

T. Khorobrykh

I.M. Sechenov First Moscow State Medical University

M. Nemtsova

I.M. Sechenov First Moscow State Medical University; Medical Genetics Research Center, Russian Academy of Medical Sciences

N. Chekunova

I.M. Sechenov First Moscow State Medical University

A. Udilova

I.M. Sechenov First Moscow State Medical University

D. Vychuzhanin

I.M. Sechenov First Moscow State Medical University

Email: vichy@list.ru

R. Nurutdinov

I.M. Sechenov First Moscow State Medical University

M. Rogal

I.M. Sechenov First Moscow State Medical University

References

  1. Василенко В.Х., Рапопорт С.И., Сальман М.М. Опухоли желудка // Клиника и диагностика. - М.: Медицина, 1999; 288 с.
  2. Вашакмадзе Л.А. Рак проксимального отдела желудка (принципы уточняющей диагностики и выбор метода лечения). Дис.. д-ра мед. наук. - М., 1991; 276 с.
  3. Клименков А.А., Неред С.Н., Губина Г.И. Современные возможности хирургического лечения рецидива рака желудка. Мат-лы VIII Российского онкологического конгресса. - М., 2004; 13-6.
  4. Клименков А.А., Ефетов В.М. Современные подходы в профилактике и лечении рака оперированного желудка. Тез. VIII Съезд онкологов УССР. -Донецк, 1990; 343-5.
  5. Клименков А.А., Неред С.Н., Губина Г.И. и др. Сорокалетний опыт хирургического лечения рецидива рака желудка // Вестн. онкологического научного центра им. Н.Н. Блохина. - 1997; 4: 28-33.
  6. Клименков А.А., Неред С.Н., Губина Г.И. Основные направления в изучении проблемы рака оперированного желудка // Вестн. РАМН. - 2001; 9: 71-4.
  7. Тимофеев Ю.М. Клиническое течение рака желудка у больных с линией резекции в зоне опухолевой ткани. Дис.. канд. мед. наук. М., 1981; 214 с.
  8. Черноусов А.Ф., Поликарпов С.А. Расширенная лимфаденэктомия в хирургии рака желудка / М, 2000.
  9. Черноусов А.Ф., Поликарпов С.А., Годжелло Э.А. Ранний рак и предопухолевые заболевания желудка / М.: ИЗДАТ. - 2002; 253 с.
  10. Чиссов В.И., Дарьялова C. Избранные лекции по онкологии. М., 2000; 670 с.
  11. Юдин А.В. Рецидивы рака желудка у больных с линией резекции в зоне опухолевой ткани. Дис.. д-ра мед. наук. М., 1999.
  12. Bai Y., Miyake S., Iwai T. et al. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene // Oncogene. - 2003; 22: 7942-9.
  13. Braga M., Molinari M., Zuliani W. et al. Surgical treatment of gastric adenocarcinoma: impact on survival and quality of life. A prospective ten year study // Hepatogastroenterology. - 1996; 43 (7): 187-93.
  14. Blair V., Martin I., Shaw D., Winship I. et al. Hereditary diffuse gastric cancer: diagnosis and management // Clin / Gastroenterol / Hepatol. - 2006; 4: 262-75.
  15. Falchetti M., Saieva C., Lupi R. et al. Gastric cancer with high-level microsatellite instability: Target gene mutations, clinicopathologic features, and long-term survival // Hum / Pathol. - 2008; 39: 925-32.
  16. Fenoglio-Preiser C., Wang J., Stemmermann G. et al. TP53 and gastric carcinoma: a review // Hum Mutat. - 2003; 21: 258-70.
  17. Giuli R. Recurrence following curative resection for gastric cancer // J. Res. Surg., 2002.
  18. Humar B., Blair V., Charlton A. et al. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man // Cancer Res. - 2009; 69: 2050-6.
  19. Honchel R., Halling K., Thibodeau S. Genomic Instability In Neoplasia. Amsterdam // Elsevier. - 1995; 6: 45-52.
  20. Kim T., Lee H., Hwang K. et al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma // Lab. Invest. -2004; 84: 479-84.
  21. Kim H., Lee J., Freund J. et al. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions // J. Gastroenterol. Hepatol. - 2006; 21: 438-42.
  22. Lehnert Т., Rudek В., Buhl K. et al. Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer // Eur. J.Surg. Oncol. - 2002; 28 (4): 455-61.
  23. Lerut T., Coosemans W., Dе Leyn P. et al. Reflections on three Field Lymphadenectomy in Carcinoma of the Esophagus and Gastro-Esophageal Junction // Hep. Gastroenterol. - 1999; 46: 717-25.
  24. Li Q., Ito K., Sakakura C. et al. Causal relationship between the loss of RUNX3 expression and gastric cancer // Cell. - 2002; 109: 113-24.
  25. Maehara Y., Emi Y., Baba H. et al. Recurrences and related characteristics of gastric cancer // Br. J. Cancer. - 1996; 74 (6): 975-9.
  26. Marelli D., Roveiello F., Manzoni G. et al. Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study // World J. Surg. - 2002; 26 (9): 1160-5.
  27. Maruyama K., Sasako M., Kinoshita T. et al. Effectiveness of Systemic Lymph Node Dissection in Gastric Cancer Surgery. In Nishi M., Ichikawa H., Nakajima T., Maruyama K., Tahara E. Gastric cancer / Springer-Verlag. - 1993; 293-306.
  28. Marx A., Tharun L., Muth J. et al. HER-2 amplification is highly homogenous in gastric cancer // Hum. Pathol. - 2009; 40: 769-77.
  29. Manzoni G., Verlato G., Guglielmi A. et al. Prognostic significance of lymph node dissection in gastric cancer // Br. J. Surg. - 1996; 83 (11): 1604-7.
  30. Mendes de Almeida J., Bettencourt A., Santos Costa C. et al. Curative surgery for gastric cancer: study of 166 consecutive patients // World J. Surg. -1995; 19: 889-95.
  31. Milne A., Carneiro F., O’Morain C. et al. Nature meets nurture: molecular genetics o gastric cancer // Hum. Genet. - 2009; 126: 615-28.
  32. Park D., Yun J., Park J. et al. HER-2/neu amplification is an independent prognostic factor in gastric cancer // Dig. Dis. Sci. - 2006; 51: 1371-9.
  33. Sakakura C., Hasegawa K., Miyagawa K. et al. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers // Clin. Cancer Res. - 2005; 11: 6479-88.
  34. Shiao Y., Rugge M., Correa P. et al. P53 alteration in gastric precancerous lesions // Am. J. Pathol. - 1994; 144: 511-7.
  35. Tanaka A., Watanabe Т., Okuno K. et al. Perineural invasion as a predictor of recurrence of gastric cancer // Cancer. - 1994; 73 (3): 550-5.
  36. Tamura G. Alterations of tumor suppressor and tumor-related genes in the develop and prognosis of gastric cancer // World J. Gastroenterol. - 2006; 12: 192-8.
  37. Wright C., Mathisen D., Wain J., Grillo H. et al. Evolution of treatment strategies for adeno-carcinoma of the esophagus and GE junction // Ann. Thorac. Surg. - 1994; 58: 1574-9.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies